Managers' transactions announcement according to article 19 MAR
Heidlelberg (pta043/05.10.2020/16:15) - Announcement
|
1
|
Details of the person discharging managerial responsibilities/person closely associated
|
|
| a) |
Name |
Dr Heikki Lanckriet |
|
2
|
Reason for the notification
|
|
| a) |
Position/status |
Member of the managing body |
| b) |
Initial notification |
|
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
| a) |
Name |
4basebio AG |
| b) |
LEI |
391200H5BDEVHMOV3U10 |
|
4
|
Details of the transaction(s)
|
|
| a) |
Description of the financial instrument, type of instrument |
Share |
| |
Identification code |
DE000A2YN801 |
| b) |
Nature of the transaction |
Sale |
| c) |
Price(s) |
Volume(s) |
| |
2.00 EUR |
554,876.00 EUR |
| d) |
Aggregated price |
Aggregated volume |
| |
2.00 EUR |
554,876.00 EUR |
| e) |
Date of the transaction |
30.09.2020 UTC+2 |
| f) |
Place of the transaction |
Outside a trading venue |
|
5
|
Explanation
|
|
| |
Sale as part of the takeover bid by Sparta AG. |
|
(end)
emitter: 4basebio AG
address: Waldhofer Str. 102, 69123 Heidelberg
country: Germany
contact person: Robert Mayer
phone: +49 171 3876540
e-mail: robert.mayer@4basebio.com
website: investors.4basebio.com
ISIN(s): DE000A2YN801 (share)
stock exchanges: regulated market in Frankfurt; free market in Stuttgart, free market in Munich, free market in Hamburg, free market in Dusseldorf; open market in Berlin, Tradegate
[ source: http://www.pressetext.com/news/20201005043 ]
|
Real-time